Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomized controlled trial : Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomized controlled trial

Media Type:

Clinical Trial

Year of Publication:

2021

Publication:

2021

Contained In:

WHO International Clinical Trials Registry Platform - (2021) vom: 03. Mai To Main Record - year:2021

Language:

Unbestimmt

Links:

Volltext [Kostenfrei]

Keywords:

610
Medical Condition: Acute respiratory distress syndrome (ARDS) associated with COVID-19 pneumonia;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Phase: Phase 2
Recruitment Status: Authorised-recruitment may be ongoing or finished
Study Type: Interventional

Notes:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 11-01-2021, Last updated: 2021-06-17

PPN (Catalogue-ID):

WHO007582765